Despite a general sense that engaging in big data analytics is important for success in the current health information technology landscape, 51% of organizations do not truly know what kind of data-or how much of it-they need to collect
More than half of providers are confused by the information collection requirements of healthcare big data analytics, finds the third annual Health IT Industry Outlook Survey by Stoltenberg Consulting. Despite a general sense that engaging in big data analytics is important for success in the current health information technology (IT) landscape, 51% of organizations do not truly know what kind of data—or how much of it—they need to collect in order to generate actionable insights from their information.
The survey, conducted at HIMSS15 in Chicago earlier this month, revealed widespread consternation and frustration when it comes to healthcare big data analytics and other health IT initiatives that are critical for strategic success.
Read more at HealthITAnalytics: http://bit.ly/1DL12kM
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
FDA Issues CRLs for Odronextamab in R/R Follicular Lymphoma, R/R DLBCL
March 25th 2024The FDA issued complete response letters (CRLs) for the biologics license application for odronextamab in relapsed/refractory (R/R) follicular lymphoma and in R/R diffuse large B-cell lymphoma (DLBCL).
Read More